Femara 2.5mg Tablets 30 for breast cancer treatment

Femara 2.5mg Tablets 30 adjuvant treatment of women after menopause who have developed early breast cancer that is hormone positive. Femara tablets is adjuvant treatment of women after menopause who have developed early breast cancer and were previously receiving adjuvant treatment with tamoxifen. First and second line treatment of women after menopause with unknown advanced breast cancer or hormone positive breast cancer, and it used for ovulation boost. Do not take Letrozole If you are allergic to Letrozole or any of the ingredients in this medicine. Tell your doctor about the allergy and what signs you had. If you have not reached menopause yet. If you are pregnant. Talk to your doctor or pharmacist if you develop allergic reactions such as shortness of breath, skin rash, swelling of the face or neck, decreased blood pressure and dizziness. This medication may affect your bone density. Your doctor may recommend bone density monitoring. This medication may increase your total cholesterol. Your doctor may recommend cholesterol monitoring. This medication may cause fatigue, drowsiness and dizziness. Do not drive or use machinery if you are not feeling well.